Insider · CIK 0001871470

Harper Molly

Reports to the SEC for 1 company · CORAL GABLES, FL

sec.gov

Transactions

Companies

Filings

CIK

0001871470

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−3,694 sh	$31.50	−$116K	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−29.5K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−23.2K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−18.1K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−1,414 sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−1,894 sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−5,468 sh	—	—	0
2025-12-29	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,334 sh	—	—	3,694
2025-12-29	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,334 sh	—	—	127,163
2025-12-12	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$5.78	+$116K	29,106
2025-12-12	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Director	SSale	−15.5K sh	$23.20	−$360K	13,579
2025-12-12	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Director	SSale	−4,473 sh	$23.73	−$106K	9,106
2025-12-12	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Director	SSale	−6,746 sh	$23.06	−$156K	2,360
2025-12-12	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	128,497
2025-12-08	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,413 sh	—	—	9,106
2025-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,413 sh	—	—	148,497
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+947 sh	—	—	7,693
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−947 sh	—	—	149,910
2025-11-20	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+18.1K sh	—	—	145,389
2025-11-20	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+5,468 sh	—	—	150,857
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	6,746
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	127,274
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,333 sh	—	—	2,746
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,333 sh	—	—	131,274
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,413 sh	—	—	1,413
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,413 sh	—	—	132,607
2024-11-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+17.5K sh	$5.78	+$101K	17,500
2024-11-27	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Director	SSale	−17.5K sh	$22.00	−$385K	0
2024-11-27	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	−17.5K sh	—	—	134,020
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+23.2K sh	—	—	148,679
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+2,841 sh	—	—	151,520
2024-06-03	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Director	SSale	−5,333 sh	$16.30	−$86.9K	0
2024-02-15	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	5,333
2024-02-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	125,431
2023-12-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,333 sh	—	—	1,333
2023-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,333 sh	—	—	129,431
2023-12-15	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Director	SSale	−4,000 sh	$14.43	−$57.7K	0
2023-12-15	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$5.78	+$57.8K	10,000
2023-12-15	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Director	SSale	−10K sh	$14.37	−$144K	0
2023-12-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	130,764
2023-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+29.5K sh	—	—	136,524
2023-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+4,240 sh	—	—	140,764
2023-02-15	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	4,000
2023-02-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	107,000
2022-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+15K sh	—	—	107,000
2022-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+4,000 sh	—	—	111,000
2022-02-14	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+12K sh	—	—	92,000

Recent filings

Accepted (ET)
Jul 174
Harper Molly0001161697-26-000177
SEC(opens sec.gov)
Dec 304
Harper Molly0001161697-25-000492
SEC(opens sec.gov)
Dec 164
Harper Molly0001161697-25-000462
SEC(opens sec.gov)
Dec 104
Harper Molly0001161697-25-000446
SEC(opens sec.gov)
Nov 244
Harper Molly0001161697-25-000417
SEC(opens sec.gov)

Companies

CATALYST PHARMACEUTICALS, INC.DirectorCPRX

Address

355 ALHAMBRA CIRCLE SUITE 801

CORAL GABLES, FL, 33134